Sociedad Americana de Hirudoterapia

Rwanda Food and Drugs Authority

Rwanda FDA · Rwanda · africa

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Rwanda's Food and Drugs Authority — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national pharmaceutical and medical device framework as appropriate.

Regulatory Profile

Agency type
national regulator
Region
africa
Country
Rwanda
Leech status
unregulated
Last ASH review
2026-05-27

Relevant Regulation Codes

  • Rwandan Law No. 003/2018 of 09/02/2018 establishing the Rwanda Food and Drugs Authority
  • Rwandan national medical device regulatory framework
  • East African Community (EAC) harmonised pharmaceutical and medical device frameworks where applicable
  • African Medicines Agency (AMA) harmonised frameworks (where applicable)

Prescriber Requirements

  • Rwanda Medical and Dental Council–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Rwanda FDA registration as applicable; English, Kinyarwanda or French-language labelling per local convention. Standard cold-chain conditions, with logistical constraints typical of landlocked East African distribution.

Import/Export Rules

Rwanda FDA and Rwanda Agriculture and Animal Resources Development Board clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Rwandan Community-Based Health Insurance (Mutuelles de Santé) and Rwanda Social Security Board coverage depend on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. East African regulatory frameworks are progressively coordinating through the East African Community (EAC) and the African Medicines Agency (AMA); whether this captures live-organism medical devices has not been independently mapped by ASH.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.